• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Venus Remedies Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4791.0
  • ISIN : INE411B01019
299.45 10 (3.38%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    285.95

  • Today’s High

    302.45

  • Open

    289.55

  • Perv Close

    289.65

  • 52W Low

    270.25

  • 52W High

    427.90

Key Indicators

  • P/E(TTM)

    9.34

  • Mar.Cap (₹Cr.)

    400.27

  • Div & Yield %

    0.00

  • Book Value(₹)

    392.45

  • Debt-Equity Ratio

    3.38

  • AGM Date

    28-Mar-2025

  • EPS

    32.08

  • P/E Ratio

    9.34

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    400.27

  • RONW (%)

    6.01

  • ROCE (%)

    8.52

Score Board

  • Equity (₹ in Cr.)

    13.37

  • BV (₹)

    392.40

  • Sales( ₹ in Cr.)

    575.21

  • NP (in Cr.)

    30.13

  • NP Var(%)

    4.0

  • Div%

    0.0

  • CPS (₹)

    41.70

  • EPS (₹)

    22.50

  • Traded Value (₹ in Lakhs)

    400.47

  • 52 Week High

    427.90

  • 52 Week Low

    270.25

  • Price BSE

    300.0

  • Price NSE

    299.00

  • Market Capital( in Cr.)

    400.47

  • P/C Ratio

    7.20

  • P/E Ratio

    13.30

  • Price Vs.BV

    22.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 575.21 537.66 576.71 514.62 320.23 301.84
Excise Duty 564.43 535.10 574.52 504.17 314.30 295.80
Net Sales 575.21 537.66 576.71 514.62 320.23 301.84
Other Income 11.32 10.17 8.43 17.76 3.58 4.51
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 586.53 547.84 585.14 532.39 323.81 306.35
EXPENDITURE :
Raw Materials 564.43 535.10 574.52 504.17 314.30 295.80
Power & Fuel Cost 564.43 535.10 574.52 504.17 314.30 295.80
Employee Cost 62.13 51.95 47.60 35.89 33.79 30.26
Other Manufacturing Expenses 0.31 0.26 0.00 0.00 0.00 0.00
Selling & Administrative Expenses 85.07 77.06 72.95 87.44 59.68 48.32
Miscellaneous Expenses 0.31 0.26 0.00 0.00 0.00 0.00
Less : Pre-operative Expenses Capitalised :
Total Expenditure 539.88 507.51 540.47 514.77 321.26 325.65
Operating Profit 14.59 10.17 9.85 7.74 6.88 7.19
Interest 0.00 0.00 0.00 12.73 13.05 25.15
Gross Profit 46.65 40.33 44.67 41.06 -6.26 -28.26
Depreciation 25.55 31.37 32.58 34.28 31.05 32.95
Profit Before Tax 46.65 40.33 44.67 41.06 -6.26 -28.26
Tax 11.74 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.93 11.36 -4.32 -13.21 1.96 -1.15
Reported Net Profit 30.50 28.96 48.99 54.27 -8.23 -27.11
Extraordinary Items 46.65 40.33 44.67 41.06 -6.26 -28.26
Adjusted Net Profit 30.50 28.96 48.99 54.27 -8.23 -27.11
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 30.50 28.96 48.99 54.27 -8.23 -27.11
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 22.82 21.67 37.12 43.97 -6.67 -21.97
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    41.76%

  • Public Share Holding

    58.24%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,300,000 17.21 2,300,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,281,997 24.55 3,281,997 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,581,997 41.76 5,581,997 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 148,469 1.11 148,469 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 148,469 1.11 148,469 4
2] Non Institution
Bodies Corporate 573,066 4.29 572,766 113
Clearing Members 1,100 0.01 1,100 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 514,929 3.85 514,929 350
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 312,919 2.34 312,919 517
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,258,807 9.42 1,258,807 26
Individuals holding nominal share capital up to Rs. 1 lakh 4,812,006 36.00 4,704,720 18,738
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 134,141 1.00 134,141 1
Sub Total 7,636,522 57.13 7,528,936 19,762
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 13,366,988 100.00 13,259,402 19,771

Company Background

Venus Remedies LtdPharmaceuticals - Indian - Formulations

  • Venus Remedies Ltd
  • BSE Code : 4791.0
  • ISIN : INE411B01019

  • Incorporation Year

    1989

  • Registered Office

    S C No 857 Cabin No 10 2nd Flr
    N A C Manimajra, Chandigarh,
    Chandigarh-160101

  • Telephone

  • FAX

  • Chairman

    Pawan Chaudhary

  • Managing Director

    Pawan Chaudhary

  • Company Secretary

    Neha Kodan

  • Auditor

    J K Jain & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    Narang Tower,
    44 Community Centre,Naraina Ind Area
    Mumbai - New Delhi-110028

Venus Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Venus Remedies 299.60 586.53 575.21 7.96 8.61
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92